drugset / Trial / NCT04345458

Safety and Efficacy Study of Prefilled Liquid Etanercept(Yisaipu) for Active Ankylosing Spondylitis

NCT04345458

RandomizedParallel-groupTriple-blindTreatment

Summary

This randomized, double-blind, phase III parallel-group non-inferiority study aimed to investigate the efficacy and safety of prefilled liquid etanercept (Yisaipu) versus lyophilized etanercept powder (Yisaipu) in active ankylosing spondylitis patients.

Timeline

Start
2014-03-06
Primary completion
2015-07-13
Completion
2015-07-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Etanercept Protein / enzyme biologic 25 mg
Comparator Etanercept Protein / enzyme biologic 50 mg